Back to RIGL

ARMISTICE CAPITAL, LLC → RIGL

ARMISTICE CAPITAL, LLC RIGL Position History

Rigel Pharmaceuticals, Inc. • Healthcare

Quarters held
5
Latest value
$74M
Q3 2026
Peak value
$74M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$20.5M
Q4 2025$35.8M
Q1 2026$34.6M
Q2 2026$65.4M
Q3 2026$74M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$74M1.54M——
Q2 2026$65.4M1.67M——
Q1 2026$34.6M1.28M——
Q4 2025$35.8M836.0K——
Q3 2025$20.5M724.0K——

Other funds holding RIGL

Other ARMISTICE CAPITAL, LLC positions

PTCT

PTC THERAPEUTICS INC

$212.8M
PTCT

PTC THERAPEUTICS ORD

$201.1M
TVTX

TRAVERE THERAPEUTICS ORD

$160.7M
IMVT

IMMUNOVANT INC

$146.1M
TVTX

TRAVERE THERAPEUTICS INC

$145.5M
TVTX

TRAVERE THERAPEUTICS INC

$143.8M
PTCT

PTC THERAPEUTICS INC

$141.3M
SUPN

SUPERNUS PHARMACEUTICALS INC

$137.4M